Skip to content

Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE)

Functional ComprEhensive AssessmenT by Intravascular UltrasoUnd Reconstruction in Patients With Suspected IschEmic Coronary Artery Disease (FEATURE)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05694065
Enrollment
112
Registered
2023-01-23
Start date
2023-02-17
Completion date
2027-12-31
Last updated
2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease

Brief summary

Investigating the diagnostic accuracy of online Ultrasonic Flow Ratio (UFR) assessment to identify hemodynamically significant coronary stenosis in patients with suspected ischemic heart disease using angiography-derived fractional flow reserve (FFR) as a reference standard.

Detailed description

1. Study overview This is a prospective, single-center, observational registry study of patients with suspected ischemic coronary artery disease. The purpose of this registry is to investigate the accuracy of online UFR assessment to identify hemodynamically significant coronary stenosis in patients with suspected ischemic heart disease using angiography-derived FFR as a reference standard. 2. Study population and sample size calculation are based on the diagnostic performance of previous studies, where an accuracy of 92% was found for UFR. Investigators conservatively estimate the diagnostic accuracy of online UFR assessment as 90% for consecutively enrolled patient population, and with a test target value set as 78% at a two-side significance level of 0.05, statistical power as 90%. Considering incomplete FFR/UFR data of 10% at most, a total of 112 patients need to be enrolled. 3. Participant enrollment was completed in November 2024; the study is currently in the follow-up phase with ongoing data collection and analysis.

Interventions

None listed

Sponsors

Ruijin Hospital
Lead SponsorOTHER
School of Biomedical Engineering, Shanghai Jiao Tong University
CollaboratorUNKNOWN
Erasmus Medical Center
CollaboratorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must be ≥ 18 years * Patients suspected with ischemic heart disease * ≥ 1 diseased vessel with angiographic percent diameter stenosis between 40% and 80% in a vessel ≥ 2.5mm by visual estimation * Target vessels are limited to major epicardial coronary arteries (left anterior descending artery \[LAD\], left circumflex artery \[LCX\], right coronary artery \[RCA\])

Exclusion criteria

* Patients with previous coronary artery bypass grafting (CABG) * Myocardial infarction within 72h of coronary angiography * Allergy to the contrast agent or adenosine * Left main coronary artery stenosis ≥ 50% * Target vessel with in-stent restenosis * Target vessel with severe tortuosity or angulation * 100% occlusion of target vessel * Target vessel spasm or injury * Target vessel with severe myocardial bridge * Target vessel with severe thrombosis * Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion * Presence of false lumen at target vessel based on IVUS * A serum creatinine level \>150 umol/l, or a glomerular filtration rate \< 45 ml/kg/1.73 m\^2 * Heart failure * Ineligible for diagnostic intervention (IVUS or FFR examination)

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic Accuracy of Onsite UFRbaselineUFR was computed as the pressure ratio across a coronary stenosis, using FFR ≤0.80 as the reference standard for hemodynamically significant stenosis. The diagnostic performance of onsite UFR was assessed by the area under the receiver operating characteristic (ROC) curve analysis, with diagnostic accuracy defined as the percentage of all correctly classified cases (true positives and true negatives) in the total population.

Secondary

MeasureTime frameDescription
Sensitivity of Onsite UFRbaselineThe diagnostic performance of onsite UFR was assessed by ROC curve analysis, using an FFR ≤0.80 as the reference standard. Sensitivity was defined as the percentage of true positives correctly identified by UFR.
Specificity of Onsite UFRbaselineThe diagnostic performance of onsite UFR was assessed by ROC curve analysis, using an FFR ≤0.80 as the reference standard. Specificity was defined as the percentage of true negatives correctly identified by UFR.
Sensitivity of Minimal Lumen Area (MLA)baselineThe diagnostic performance of MLA was assessed by ROC curve analysis, using an FFR ≤0.80 as the reference standard. Sensitivity was defined as the percentage of true positives correctly identified by the prespecified MLA cutoff value.
Specificity of MLAbaselineThe diagnostic performance of MLA was assessed by ROC curve analysis, using an FFR ≤0.80 as the reference standard. Specificity was defined as the percentage of true negatives correctly identified by the prespecified MLA cutoff value.

Countries

China

Contacts

PRINCIPAL_INVESTIGATORFenghua Ding, MD, PhD

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Participant flow

Participants by arm

ArmCount
Functional Assessment in Patients With Suspected Ischemic Heart Disease
Onsite UFR and FFR Assessment in Patients with Suspected Ischemic Heart Disease
106
Total106

Baseline characteristics

CharacteristicFunctional Assessment in Patients With Suspected Ischemic Heart Disease
Age, Continuous68.5 years
Body Mass Index (BMI)24.6 Kg/m^2
STANDARD_DEVIATION 3.2
Sex: Female, Male
Female
30 Participants
Sex: Female, Male
Male
76 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Diagnostic Accuracy of Onsite UFR

UFR was computed as the pressure ratio across a coronary stenosis, using FFR ≤0.80 as the reference standard for hemodynamically significant stenosis. The diagnostic performance of onsite UFR was assessed by the area under the receiver operating characteristic (ROC) curve analysis, with diagnostic accuracy defined as the percentage of all correctly classified cases (true positives and true negatives) in the total population.

Time frame: baseline

Population: Six participants were excluded according to the predefined exclusion criteria.

ArmMeasureValue (NUMBER)
Functional Assessment in Patients With Suspected Ischemic Heart DiseaseDiagnostic Accuracy of Onsite UFR94 percentage of correctly classified cases
Secondary

Sensitivity of Minimal Lumen Area (MLA)

The diagnostic performance of MLA was assessed by ROC curve analysis, using an FFR ≤0.80 as the reference standard. Sensitivity was defined as the percentage of true positives correctly identified by the prespecified MLA cutoff value.

Time frame: baseline

Population: Six participants were excluded according to the predefined exclusion criteria.

ArmMeasureValue (NUMBER)
Functional Assessment in Patients With Suspected Ischemic Heart DiseaseSensitivity of Minimal Lumen Area (MLA)47 percentage of true positives
Secondary

Sensitivity of Onsite UFR

The diagnostic performance of onsite UFR was assessed by ROC curve analysis, using an FFR ≤0.80 as the reference standard. Sensitivity was defined as the percentage of true positives correctly identified by UFR.

Time frame: baseline

Population: Six participants were excluded according to the predefined exclusion criteria.

ArmMeasureValue (NUMBER)
Functional Assessment in Patients With Suspected Ischemic Heart DiseaseSensitivity of Onsite UFR88 percentage of true positives
Secondary

Specificity of MLA

The diagnostic performance of MLA was assessed by ROC curve analysis, using an FFR ≤0.80 as the reference standard. Specificity was defined as the percentage of true negatives correctly identified by the prespecified MLA cutoff value.

Time frame: baseline

Population: Six participants were excluded according to the predefined exclusion criteria.

ArmMeasureValue (NUMBER)
Functional Assessment in Patients With Suspected Ischemic Heart DiseaseSpecificity of MLA84 percentage of true negatives
Secondary

Specificity of Onsite UFR

The diagnostic performance of onsite UFR was assessed by ROC curve analysis, using an FFR ≤0.80 as the reference standard. Specificity was defined as the percentage of true negatives correctly identified by UFR.

Time frame: baseline

Population: Six participants were excluded according to the predefined exclusion criteria.

ArmMeasureValue (NUMBER)
Functional Assessment in Patients With Suspected Ischemic Heart DiseaseSpecificity of Onsite UFR97 percentage of true negatives

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026